Ondine Biomedical Inc. (OBI)
LSE
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Return on Assets (%) | -158.045 | -333.465 | -375.118 | -586.554 | -272.386 | -76.405 | -129.238 |
Return on Equity (%) | 205.264 | 137.855 | 63.223 | 54.326 | 2401.582 | -93.809 | -209.95 |
Return on Invested Capital (%) | 183.482 | 134.873 | 63.687 | 52.915 | 816.04 | -91.016 | -224.676 |
Operating Margin (%) | -1365.291 | -4517.426 | -2957.112 | -881.072 | -1902.919 | -3031.661 | -1194.846 |
Net Profit Margin (%) | -1561.65 | -4517.426 | -2995.69 | -908.487 | -1949.591 | -3036.364 | -1198.005 |
Book Value Per Share | -12.9 | -28.1 | -38.3 | -48.1 | 15.2 | 6 | 0.9 |
Earnings Per Share | -9.1 | -23.8 | -19.7 | -23 | -25.7 | -10 | -6.4 |
Cash Per Share | 2.5 | 1.9 | 0.4 | 0.9 | 15.6 | 6.7 | 1.3 |
Working Capital Per Share | -13.2 | -28.4 | -39.1 | -48.2 | 15.2 | 5.8 | 0.6 |
Operating Profit Per Share | 0.5 | -0.2 | 0.2 | 0.9 | 0.7 | 0.2 | 0.3 |
EBIT Per Share | -9.1 | -23.8 | -19.7 | -23 | -25.7 | -10 | -6.4 |
EBITDA Per Share | -9.1 | -23.8 | -19.7 | -23 | -25.7 | -10 | -6.4 |
Free Cash Flow Per Share | -8.7 | -24.9 | -21.3 | -24.5 | -26 | -10 | -6.5 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 70,67M | 70,67M | 70,67M | 70,67M | 194,58M | 194,59M | 226,75M |
Capitalisation boursière | 44,44M |
Ratio cours/bénéfice | -3,08 |
Ratio prix/ventes | 36,67 |
Ratio prix/liquidités | 14,86 |
Ratio prix/valeur comptable | 21,31 |
Rendement de dividende | - |
Actions en circulation | 404M |
Volume moyen (1 semaine) | 602,31k |
Volume moyen (1 mois) | 285,34k |
Variation sur 52 semaines | 17,33% |
Plus haut sur 52 semaines | 11,75 |
Plus bas sur 52 semaines | 4,50 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales